IVD Medical Holding Limited (1931.HK)

HKD 1.53

(-4.38%)

EBITDA Summary of IVD Medical Holding Limited

  • IVD Medical Holding Limited's latest annual EBITDA in 2023 was 397.92 Million CNY , up 16.66% from previous year.
  • IVD Medical Holding Limited's latest quarterly EBITDA in 2024 Q2 was 199.87 Million CNY , down 0.0% from previous quarter.
  • IVD Medical Holding Limited reported an annual EBITDA of 349.65 Million CNY in 2022, up 25.04% from previous year.
  • IVD Medical Holding Limited reported an annual EBITDA of 286.17 Million CNY in 2021, up 14.45% from previous year.
  • IVD Medical Holding Limited reported a quarterly EBITDA of 219.52 Million CNY for 2023 Q4, down 0.0% from previous quarter.
  • IVD Medical Holding Limited reported a quarterly EBITDA of 180.81 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of IVD Medical Holding Limited (2023 - 2016)

Historical Annual EBITDA of IVD Medical Holding Limited (2023 - 2016)

Year EBITDA EBITDA Growth
2023 397.92 Million CNY 16.66%
2022 349.65 Million CNY 25.04%
2021 286.17 Million CNY 14.45%
2020 250.04 Million CNY -21.57%
2019 318.8 Million CNY 384.83%
2018 65.75 Million CNY -53.07%
2017 67.54 Million CNY 80.43%
2016 77.48 Million CNY 0.0%

Peer EBITDA Comparison of IVD Medical Holding Limited

Name EBITDA EBITDA Difference
Wanjia Group Holdings Limited -29.02 Million HKD 1470.984%
China Health Group Limited -37.41 Million HKD 1163.438%
Tai United Holdings Limited -1.18 Billion HKD 133.575%